A Randomized, Open-label, Parallel-group, Active-control PK/PD Study of Two Doses of Leuprolide Oral Tablets in Comparison to an IM Dose of Leuprolide in Healthy Female Volunteers
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Leuprorelin (Primary)
- Indications Endometriosis
- Focus Pharmacodynamics
- Sponsors Enteris BioPharma
- 01 Feb 2018 Planned number of patients changed from 32 to 24.
- 01 Feb 2018 Planned End Date changed from 1 Oct 2017 to 1 Dec 2018.
- 01 Feb 2018 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2018.